The Australian share market is home to a good number of high quality blue chip shares for investors to choose from. But with so much choice, it can be hard to decide which ones to buy.
To narrow things down for you, I've picked out three blue chip shares which I think would be great additions to a balanced portfolio this week.
They are as follows:
CSL Limited (ASX: CSL)
Although this biotherapeutics giant's shares have just hit a record high, I still see value in them for long-term focused investors. I think CSL is one of the highest quality companies Australia has produced. It is made up of two businesses – CSL Behring and Seqirus. CSL Behring is the global leader in plasma therapies and Seqirus is the second biggest in the influenza vaccines industry. I believe both businesses have strong long-term growth potential due to favourable industry dynamics, their leading products, and burgeoning research and development pipelines.
REA Group Limited (ASX: REA)
Another blue chip share to consider is this property listings company. I expect the recent rebound in the housing market to be a big positive for REA Group. As more and more houses come onto the market, REA Group should see demand for listings accelerate. Another bonus is its recent price increases and new revenue streams. Combined, I feel this positions the company perfectly for strong earnings growth over the next decade. In addition to this, its growing international operations are likely to support its core business.
Telstra Corporation Ltd (ASX: TLS)
I've been very impressed with the way Telstra has turned around its fortunes over the last 18 months and believe it is well positioned to return to growth in the near future. This is due to the return of rational competition in the telco industry, its T22 cost-cutting plans, and its leadership position in the 5G market. In light of this, I feel now could be an opportune time to consider a patient long-term investment in the telco giant's shares.
